Showing results (251-260 of 339) with videos related to

Sort By:
Pageof 34
Blood Advances|August 9, 2018
Outcomes of patients who developed subsequent solid cancer after hematopoietic cell transplantationYoshihiro Inamoto, Tomohiro Matsuda, Ken Tabuchi, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 4, 2022
[Haploidentical hematopoietic stem cell transplantation for graft failure in myelodysplastic syndrome/myeloproliferative neoplasm-unclassifiable complicated with Stenotrophomonas maltophilia bacteremia]Junichi Mukae, Noritaka Sekiya, Chika Kato, et al.
International Journal of Hematology|October 15, 2021
Retrospective comparison of hematopoietic stem cell transplantation following reduced-intensity conditioning with fludarabine/low-dose melphalan plus 4 Gy TBI versus fludarabine/ busulfan plus 4 Gy TBIYuta Yamada, Shuntaro Ikegawa, Yuho Najima, et al.
Open Forum Infectious Diseases|April 24, 2023
Association Between Candidemia and Noninfectious Interstitial Pneumonia After Allogeneic Hematopoietic Cell Transplantation: JSTCT Transplant Complications Working GroupShun-Ichi Kimura, Yu Akahoshi, Souichi Shiratori, et al.
Annals of Hematology|November 19, 2024
Reappraising the prognostic relevance of cytogenetic risk in patients with acute myeloid leukemia undergoing allogeneic hematopoietic cell transplantationShohei Mizuno, Hiroki Hosoi, Akiyoshi Takami, et al.
Bone Marrow Transplantation|February 20, 2020
A prospective trial of vaccine to prevent hepatitis B virus reactivation after hematopoietic stem cell transplantationKoji Nishikawa, Kiminori Kimura, Yoshinobu Kanda, et al.
Transplantation|February 14, 2025
Impact of HLA Epitope Matching on Outcomes in Haploidentical HSCT With Distinct GVHD ProphylaxesMakoto Iwasaki, Junya Kanda, Hidenori Tanaka, et al.
Transplantation and Cellular Therapy|July 3, 2024
Real-World Outcomes of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation in Japan: Retrospective Analysis of the Transplant Registry Unified Management Program RegistryJunya Kanda, Takaya Mitsuyoshi, Masatoshi Sakurai, et al.
Blood Advances|January 15, 2026
GVHD prophylaxis after cord blood transplantation in patients with high-risk AML: a nationwide Japanese cohort studySatoshi Yamasaki, Masamitsu Yanada, Shohei Mizuno, et al.
Cancer Medicine|August 28, 2023
Clinical outcomes in transplant-eligible patients with relapsed or refractory diffuse large B-cell lymphoma after second-line salvage chemotherapy: A retrospective studyYu Yagi, Yusuke Kanemasa, Yuki Sasaki, et al.
Pageof 34